Qube Research & Technologies (QRT)
RVPH

Qube Research & Technologies (QRT)’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3
Closed -$64 – 3988
2024
Q2 		$64 Sell
3
-1,073
-100% -$48.8K ﹤0.01% 3472
2024
Q1 		$81.3K Sell
1,076
-692
-39% -$54.8K ﹤0.01% 3377
2023
Q4 		$182K Buy
1,768
+1,617
+1,071% +$145K ﹤0.01% 2834
2023
Q3 		$14.8K Buy
+151
New +$14.1K ﹤0.01% 3232

Other funds holding RVPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
ECM
EMC Capital Management Houston, Texas $225M AUM 25.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RVPH Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q3 2024, closing a stake of 3 shares — an estimated $64 sold.

Qube Research & Technologies (QRT) first reported a position in RVPH in Q3 2023 and held it in 4 quarters. The position peaked at $182K in Q4 2023. 33 funds tracked by Wall St. Rank hold RVPH as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining REVIVA PHARMA HLDGS INC position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3 REVIVA PHARMA HLDGS INC shares in Q3 2024, an estimated $64.
  • Qube Research & Technologies (QRT) first reported a position in REVIVA PHARMA HLDGS INC in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s REVIVA PHARMA HLDGS INC position peaked at $182K in Q4 2023.
  • 33 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.